The role of surgery in metastatic breast cancer

scientific article published on September 2011

The role of surgery in metastatic breast cancer is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0959-8049(11)70142-3
P698PubMed publication ID21944030

P2093author name stringMiranda F Ernst
Jetske Ruiterkamp
P2860cites workHypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patientsQ24806202
Circulating tumor cells, disease progression, and survival in metastatic breast cancerQ29619276
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival ratesQ30872798
Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival dataQ30967346
The role of surgery in the management of solitary pulmonary nodule in breast cancer patientsQ79699195
Radiofrequency ablation of liver metastases from breast cancer: results in 14 patientsQ79765535
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic diseaseQ79787098
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalQ79954604
Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatmentQ80092296
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trialQ80495823
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastasesQ80516622
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancerQ81098394
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancerQ81312783
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysisQ81353372
Favourable long-term results after surgical removal of lung metastases of breast cancerQ81360405
Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patientsQ81528236
Surgery for pulmonary nodules in breast cancer patientsQ81690428
Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapyQ82056334
Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancerQ82758446
Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patientsQ82847059
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the NetherlandsQ83219611
Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosisQ83349364
Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosisQ83737832
Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedureQ84384384
Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow upQ73816218
[Hepatic resection for breast cancer metastases: results and prognosis (65 cases)]Q74182360
Thermoradiotherapy for locally recurrent breast cancer with skin involvementQ74262293
Long-term follow-up of a randomized trial on adjuvant chemotherapy and hormonal therapy in locally advanced breast cancerQ74601289
Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patientsQ77525781
Does aggressive local therapy improve survival in metastatic breast cancer?Q78449283
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patientsQ33284025
Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER dataQ33285612
Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer.Q33778000
Is breast cancer survival improving?Q34285880
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerQ34398320
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trialQ34444401
An attempt to clarify indications for hepatectomy for liver metastases from breast cancerQ35057199
A role for curative surgery in the treatment of selected patients with metastatic breast cancerQ35139625
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?Q35820247
Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?Q35860886
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patientsQ35976141
Management of bone metastases in breast cancerQ36046266
The use of radiofrequency in cancerQ36116078
Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.Q36160476
Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patientsQ36384461
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumorQ36449271
Systemic treatments for inflammatory breast cancer.Q36492965
The role of external beam radiotherapy in the management of bone metastasesQ36682987
Point: Hyperthermia with radiation for chest wall recurrencesQ36794038
Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasisQ36905539
Radiofrequency ablation in the management of liver metastases from breast cancerQ36947866
Timing of surgical intervention for the intact primary in stage IV breast cancer patientsQ37115503
Treatment of metastatic breast cancer: looking towards the futureQ37157576
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survivalQ37200654
Matched pair analyses of stage IV breast cancer with or without resection of primary breast siteQ37251791
Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literatureQ37655594
Axillary staging in the neoadjuvant settingQ37709210
Locally advanced breast cancer: defining an optimum treatment regimen.Q40730740
Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinomaQ41601181
Effects of surgical excision on survival of patients with stage IV breast cancerQ43528967
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experienceQ43703303
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyQ43724292
Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patientsQ43915926
The effect of systemic therapy on local-regional control in locally advanced breast cancerQ44002831
The prognostic significance of late local recurrence after breast-conserving therapyQ44212905
Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsyQ44219353
Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.Q44834877
The results of radiation therapy for isolated local regional recurrence after mastectomyQ44908330
Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical studyQ45101678
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centreQ45206850
Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancerQ45229213
Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancerQ45627568
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancerQ45854680
Association of surgery with improved survival in stage IV breast cancer patientsQ46625611
The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastasesQ46916364
Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosisQ47176205
Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancerQ48145774
Surgical treatment of 70 patients with brain metastases from breast carcinomaQ48598959
Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients.Q48829522
Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy.Q50478606
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.Q50563037
Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases.Q51353165
Pulmonary metastases of breast cancer. When is resection indicated?Q51681105
Clinical features of surgical resection for pulmonary metastasis from breast cancer.Q51698102
Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.Q51766155
Is liver resection justified for patients with hepatic metastases from breast cancer?Q51775751
Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease.Q52882024
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.Q53012804
Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases.Q53311270
CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.Q53408071
Multimodality therapy in inflammatory breast cancer: is there a place for surgery?Q53769598
Presentation, management and outcome of axillary recurrence from breast cancer.Q54027013
The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 proceduresQ59721943
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trialsQ60594506
Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgeryQ62128623
Uncertain benefit from surgery in patients with lung metastases from breast carcinomaQ62785649
Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinomaQ63353119
Isolated local-regional recurrence following mastectomy for adenocarcinoma of the breast treated with radiation therapy alone or combined with surgery and/or chemotherapyQ67941699
Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breastQ68020168
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)Q69499715
Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trialQ69520541
The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomyQ69587568
Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapyQ69619903
Inflammatory carcinoma of the breast: treatment results on 107 patientsQ69666333
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiationQ69884400
Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patientsQ71116491
Mastectomy in the management of patients with inflammatory breast cancerQ71801979
Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III TrialQ71975335
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancerQ72616300
Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysisQ73292298
Salvage radiotherapy for local failures of lumpectomy and breast irradiationQ73301116
Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancerQ73341194
Disease-free survival after resection of lung metastases in patients with breast cancerQ73699135
Liver metastases from breast cancer: long-term survival after curative resectionQ73701691
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized TrialQ73792149
Surgical treatment of hepatic metastases from breast cancerQ73806402
P921main subjectmetastatic breast cancerQ12859063
P304page(s)S6-22
P577publication date2011-09-01
P1433published inEuropean Journal of CancerQ332260
P1476titleThe role of surgery in metastatic breast cancer
P478volume47 Suppl 3

Reverse relations

cites work (P2860)
Q38029563A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).
Q92990842Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)
Q55111538Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.
Q58752612Could local surgery improve survival in de novo stage IV breast cancer?
Q35894515DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
Q30317067ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
Q46896796First site of recurrence after breast cancer adjuvant treatment in the era of multimodality therapy: which imaging for which patient during follow-up?
Q29248323Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
Q33823590Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Q38677028Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?
Q38576929Liver Ablation: Best Practice.
Q37653376Liver resection for HER2-enriched breast cancer metastasis: case report and review of the literature
Q38104240Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature.
Q36198921Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care
Q36702139Pathways to breast cancer recurrence.
Q37625349Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapy
Q92865310Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life
Q37386094Primary surgical treatment of locally advanced breast cancer in low resource settings
Q36277982Progesterone regulates the proliferation of breast cancer cells - in vitro evidence
Q58564534Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis
Q86878792Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease
Q33759443Radiotherapy in patients with distant metastatic breast cancer
Q37937872Radiotherapy in patients with metastatic breast cancer
Q47915753Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Q35758296Surgical resection of a liver metastasis from breast cancer
Q92690953Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis
Q38990182The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients
Q38152342Thyroid metastasectomy
Q36706395β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases